首页> 美国卫生研究院文献>Medical Science Monitor : International Medical Journal of Experimental and Clinical Research >Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study
【2h】

Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study

机译:中枢神经系统(CNS)原发性弥漫性大B细胞淋巴瘤(DLBCL)的磁共振成像和血管形态学中的延迟对比增强:一项回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThis study aimed to compare the magnetic resonance imaging (MRI) findings of primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS) with delayed contrast enhancement and histological microvessel density (MVD). T1-weighted and T2-weighted contrast-enhanced and non-enhanced brain imaging were used. CNS lymphoma tissue was evaluated using primary antibodies to endothelial cells and smooth muscle cells, and histochemical staining for reticulin fibers and basement membrane, which allowed quantification of the MVD.
机译:背景本研究旨在比较中枢神经系统(CNS)原发性弥漫性大B细胞淋巴瘤(DLBCL)与延迟增强造影剂和组织学微血管密度(MVD)的磁共振成像(MRI)结果。使用T1加权和T2加权对比增强和非增强脑成像。使用针对内皮细胞和平滑肌细胞的一抗以及网织蛋白纤维和基底膜的组织化学染色对中枢神经系统淋巴瘤组织进行评估,从而可以对MVD进行定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号